Differences in toxicity due to species variation in the metabolism of an oral anti-allergy agent [proceedings]

D A Smith. Br J Pharmacol. 1979 Jul.

. 1979 Jul;66(3):422P-423P.

No abstract available

Similar articles

Chromone-2-carboxylic acids: roles of acidity and lipophilicity in drug disposition.
Smith DA, Brown K, Neale MG. Smith DA, et al. Drug Metab Rev. 1985-1986;16(4):365-88. doi: 10.3109/03602538508991440. Drug Metab Rev. 1985. PMID: 3915471 Review. No abstract available.
Pharmacology of the specific histamine H1-antagonist astemizole.
Awouters FH, Niemegeers CJ, Janssen PA. Awouters FH, et al. Arzneimittelforschung. 1983;33(3):381-8. Arzneimittelforschung. 1983. PMID: 6135428 No abstract available.
Anti-allergy properties of PRD-92-Ea [5,5-dimethyl-11-oxo 5H, 11H-(2) benzopyrano (4,3-g) (1) benzopyran-9-carboxylic acid ethanolamine] [proceedings].
Beets JL, Meade H, Morley J. Beets JL, et al. Br J Pharmacol. 1978 Mar;62(3):423P. Br J Pharmacol. 1978. PMID: 25105 Free PMC article. No abstract available.
Profiles of different anti-allergy effects of a new histamine antagonist, BM 15,100 [proceedings].
Assem ES, Chong EK. Assem ES, et al. Br J Pharmacol. 1976 Jul;57(3):437P-438P. Br J Pharmacol. 1976. PMID: 10032 Free PMC article. No abstract available.
Pharmacological treatment of allergies.
De Vos C. De Vos C. Allerg Immunol (Paris). 1992 Dec;24(10):382-4. Allerg Immunol (Paris). 1992. PMID: 1363195 Review.